P

Inventor

SHEIKH AHMAD Y

US24 patents
⚠️ This page may combine multiple inventors who share the name “SHEIKH AHMAD Y”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBVIE INC

17 patents
US10017517B2Jul 10, 2018

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluorethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ABBVIE INC41 citations98
US11198697B1Dec 14, 2021

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ABBVIE INC29 citations97
US11186584B2Nov 30, 2021

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ABBVIE INC28 citations97
US10981923B2Apr 20, 2021

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ABBVIE INC32 citations97
US9879018B2Jan 30, 2018

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl and solid state forms thereof

ABBVIE INC42 citations95
US9879019B2Jan 30, 2018

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ABBVIE INC42 citations94
US11680069B2Jun 20, 2023

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ABBVIE INC6 citations93
US11661425B2May 30, 2023

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ABBVIE INC9 citations93
US11512092B2Nov 29, 2022

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ABBVIE INC21 citations93
US9856286B2Jan 2, 2018

2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof

ABBVIE INC14 citations90
US12110298B2Oct 8, 2024

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ABBVIE INC1 citations83
US11117927B2Sep 14, 2021

2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof

ABBVIE INC3 citations71
US9469673B2Oct 18, 2016

Crystaline forms of HCV inhibitor

ABBVIE INC4 citations68
US9321807B2Apr 26, 2016

Crystal forms

ABBVIE INC2 citations61
US9561181B2Feb 7, 2017

Crystal forms

ABBVIE INC0 citations51
US8592589B2Nov 26, 2013

Methods of treating cancer with a thieno[3,2-C]pyridine

ABBVIE INC0 citations51
US8357804B2Jan 22, 2013

Crystal forms of kinase inhibitors

ABBVIE INC0 citations51

ABBOTT LAB

2 patents

REATA PHARMACEUTICALS HOLDINGS LLC

2 patents

PHARMACIA CORP

1 patent

ZHANG GEOFF G Z

1 patent

COWART MARLON D

1 patent